Feedback / Questions
onvitrelin ucalontide (AT-101) - A28 Therap
https://www.prnewswire.com/news-releases/a28-therapeutics-and-gatc-health-announce-comprehensive-ai-powered-analysis-predicting-efficacy-safety-and-potential-off-target-effects-of-a28s-at-101-cancer-drug-candidate-302348205.html
Jan 13, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next